[What is the value of neoadjuvant therapy in bronchial carci…
Emerging
0
Citations0
Refs2000
Year
Search Works
Work Details
- PMID https://pubmed.ncbi.nlm.nih.gov/10829310
- OpenAlex ID W2404042595
- Type Other
- Language EN
- Published 01 Jan 2000
- Volume 125 (4)
- Pages 315–8
- Source PubMed
- Publisher National Institutes of Health
- Countries 1
- Institutions 2
- Added 24 Jun 2016
- Updated 29 Sep 2026
External Links
MENU
0
[What is the value of neoadjuvant therapy in bronchial carcinoma?].
Other 2000 EN
Neoadjuvant chemotherapy is obligatory for small-cell lung cancer. When combined with radio-therapy, it reduces the incidence of recurrence and increases the survival rate to a level similar to that seen in non-small-cell lung cancer. Preliminary results suggest that complete remissions (3-year-survival rate 56%) can be achieved through the use of chemotherapy, possibly including high-dose chemoth…
0
Citations
0
References
3
Authors
0.00
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | W. Digel | University of Freiburg (DE) University Medical Center Frei… (DE) | — |
| 2 | L Brethner | — | — |
| 3 | J Hasse | — | — |
Related Works
10Data: OpenAlex